Journal of Inflammation Research-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2239946, encodeId=726f223994627, content=修改后第二轮送审了，有没有同样经历的老师，第二次送审要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Fri Nov 29 17:53:19 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2229945, encodeId=6eb72229945a9, content=请问下大家2Ereport sent to editor in chief 到给出第一次意见用了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Wed Oct 09 13:33:16 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2241724, encodeId=7ce42241e2478, content=偏重的研究方向：免疫;肿瘤;炎症 经验分享：1AB 快2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Tue Dec 10 20:16:47 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241649, encodeId=57ea2241649e8, content=审稿速度:3.0 经验分享：2B已经1个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PvPuPKyGgyEFjOnEQlhibAbJCaAxIq6qJEXfBCYLEEvWnkSk4d3ia5YR5nmnImc4JRRibH2iavHXMtlfX72hGg7RpA/132, createdBy=435e5183220, createdName=曼朵朵, createdTime=Tue Dec 10 10:23:16 CST 2024, time=2024-12-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2203444, encodeId=974e22034441c, content=请问3CX是要拒稿的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ceb5426566, createdName=ms7000001759450297, createdTime=Wed May 08 13:27:16 CST 2024, time=2024-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2240974, encodeId=a5bf22409e426, content=熬过了1a，又卡到了2E，这一步你们都用了多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Thu Dec 05 16:29:26 CST 2024, time=2024-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241160, encodeId=5da1224116001, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：一个月了现在2B，持续了10天……等待中，不知道这个杂志好中不？临床标志物和预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=051e2959338, createdName=cyz01, createdTime=Sat Dec 07 00:18:16 CST 2024, time=2024-12-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2241047, encodeId=0b0c224104e97, content=Conflict of Interest The Author is responsible for collecting disclosure information for each of the co-authors in a multi-authored paper. DMP's editor(s) will determine what disclosures, if any, should be made available with the published Paper. 作者负责收集多作者论文中每位合著者的披露信息。DMP 的编辑将决定应与已发布的论文一起提供哪些披露（如果有）。这句话的意思是投稿之后只有第一个作者收到确认信息，其他作者收不到投稿邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c578489111, createdName=ms2000001896994207, createdTime=Fri Dec 06 09:59:59 CST 2024, time=2024-12-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2239408, encodeId=ab39223940840, content=有兄弟遇到过3A Provisional acceptance这个状态吗？是直接接收的意思吗？心里好忐忑……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Nov 27 00:01:55 CST 2024, time=2024-11-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2239874, encodeId=b1a922398e48b, content=偏重的研究方向：心脏;炎症 经验分享：大家有过5AB：Final decision confirmation pending这个状态吗？这个是快要接收了还是不确定啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9eb25579326, createdName=一个胖子YH, createdTime=Fri Nov 29 09:30:45 CST 2024, time=2024-11-29, status=1, ipAttribution=山东省)]

2024-11-29 ms4000000082043336 来自河南省

修改后第二轮送审了，有没有同样经历的老师，第二次送审要多久啊

9 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2239946, encodeId=726f223994627, content=修改后第二轮送审了，有没有同样经历的老师，第二次送审要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Fri Nov 29 17:53:19 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2229945, encodeId=6eb72229945a9, content=请问下大家2Ereport sent to editor in chief 到给出第一次意见用了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Wed Oct 09 13:33:16 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2241724, encodeId=7ce42241e2478, content=偏重的研究方向：免疫;肿瘤;炎症 经验分享：1AB 快2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Tue Dec 10 20:16:47 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241649, encodeId=57ea2241649e8, content=审稿速度:3.0 经验分享：2B已经1个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PvPuPKyGgyEFjOnEQlhibAbJCaAxIq6qJEXfBCYLEEvWnkSk4d3ia5YR5nmnImc4JRRibH2iavHXMtlfX72hGg7RpA/132, createdBy=435e5183220, createdName=曼朵朵, createdTime=Tue Dec 10 10:23:16 CST 2024, time=2024-12-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2203444, encodeId=974e22034441c, content=请问3CX是要拒稿的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ceb5426566, createdName=ms7000001759450297, createdTime=Wed May 08 13:27:16 CST 2024, time=2024-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2240974, encodeId=a5bf22409e426, content=熬过了1a，又卡到了2E，这一步你们都用了多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Thu Dec 05 16:29:26 CST 2024, time=2024-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241160, encodeId=5da1224116001, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：一个月了现在2B，持续了10天……等待中，不知道这个杂志好中不？临床标志物和预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=051e2959338, createdName=cyz01, createdTime=Sat Dec 07 00:18:16 CST 2024, time=2024-12-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2241047, encodeId=0b0c224104e97, content=Conflict of Interest The Author is responsible for collecting disclosure information for each of the co-authors in a multi-authored paper. DMP's editor(s) will determine what disclosures, if any, should be made available with the published Paper. 作者负责收集多作者论文中每位合著者的披露信息。DMP 的编辑将决定应与已发布的论文一起提供哪些披露（如果有）。这句话的意思是投稿之后只有第一个作者收到确认信息，其他作者收不到投稿邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c578489111, createdName=ms2000001896994207, createdTime=Fri Dec 06 09:59:59 CST 2024, time=2024-12-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2239408, encodeId=ab39223940840, content=有兄弟遇到过3A Provisional acceptance这个状态吗？是直接接收的意思吗？心里好忐忑……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Nov 27 00:01:55 CST 2024, time=2024-11-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2239874, encodeId=b1a922398e48b, content=偏重的研究方向：心脏;炎症 经验分享：大家有过5AB：Final decision confirmation pending这个状态吗？这个是快要接收了还是不确定啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9eb25579326, createdName=一个胖子YH, createdTime=Fri Nov 29 09:30:45 CST 2024, time=2024-11-29, status=1, ipAttribution=山东省)]

2024-10-09 ms9000002057290162 来自浙江省

请问下大家2Ereport sent to editor in chief 到给出第一次意见用了多久啊

27 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2239946, encodeId=726f223994627, content=修改后第二轮送审了，有没有同样经历的老师，第二次送审要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Fri Nov 29 17:53:19 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2229945, encodeId=6eb72229945a9, content=请问下大家2Ereport sent to editor in chief 到给出第一次意见用了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Wed Oct 09 13:33:16 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2241724, encodeId=7ce42241e2478, content=偏重的研究方向：免疫;肿瘤;炎症 经验分享：1AB 快2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Tue Dec 10 20:16:47 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241649, encodeId=57ea2241649e8, content=审稿速度:3.0 经验分享：2B已经1个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PvPuPKyGgyEFjOnEQlhibAbJCaAxIq6qJEXfBCYLEEvWnkSk4d3ia5YR5nmnImc4JRRibH2iavHXMtlfX72hGg7RpA/132, createdBy=435e5183220, createdName=曼朵朵, createdTime=Tue Dec 10 10:23:16 CST 2024, time=2024-12-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2203444, encodeId=974e22034441c, content=请问3CX是要拒稿的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ceb5426566, createdName=ms7000001759450297, createdTime=Wed May 08 13:27:16 CST 2024, time=2024-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2240974, encodeId=a5bf22409e426, content=熬过了1a，又卡到了2E，这一步你们都用了多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Thu Dec 05 16:29:26 CST 2024, time=2024-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241160, encodeId=5da1224116001, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：一个月了现在2B，持续了10天……等待中，不知道这个杂志好中不？临床标志物和预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=051e2959338, createdName=cyz01, createdTime=Sat Dec 07 00:18:16 CST 2024, time=2024-12-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2241047, encodeId=0b0c224104e97, content=Conflict of Interest The Author is responsible for collecting disclosure information for each of the co-authors in a multi-authored paper. DMP's editor(s) will determine what disclosures, if any, should be made available with the published Paper. 作者负责收集多作者论文中每位合著者的披露信息。DMP 的编辑将决定应与已发布的论文一起提供哪些披露（如果有）。这句话的意思是投稿之后只有第一个作者收到确认信息，其他作者收不到投稿邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c578489111, createdName=ms2000001896994207, createdTime=Fri Dec 06 09:59:59 CST 2024, time=2024-12-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2239408, encodeId=ab39223940840, content=有兄弟遇到过3A Provisional acceptance这个状态吗？是直接接收的意思吗？心里好忐忑……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Nov 27 00:01:55 CST 2024, time=2024-11-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2239874, encodeId=b1a922398e48b, content=偏重的研究方向：心脏;炎症 经验分享：大家有过5AB：Final decision confirmation pending这个状态吗？这个是快要接收了还是不确定啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9eb25579326, createdName=一个胖子YH, createdTime=Fri Nov 29 09:30:45 CST 2024, time=2024-11-29, status=1, ipAttribution=山东省)]

2024-12-10 Doctorfan 来自上海

偏重的研究方向：免疫;肿瘤;炎症
经验分享：1AB 快2周了

7 0

[GetPortalCommentsPageByObjectIdResponse(id=2239946, encodeId=726f223994627, content=修改后第二轮送审了，有没有同样经历的老师，第二次送审要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Fri Nov 29 17:53:19 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2229945, encodeId=6eb72229945a9, content=请问下大家2Ereport sent to editor in chief 到给出第一次意见用了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Wed Oct 09 13:33:16 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2241724, encodeId=7ce42241e2478, content=偏重的研究方向：免疫;肿瘤;炎症 经验分享：1AB 快2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Tue Dec 10 20:16:47 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241649, encodeId=57ea2241649e8, content=审稿速度:3.0 经验分享：2B已经1个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PvPuPKyGgyEFjOnEQlhibAbJCaAxIq6qJEXfBCYLEEvWnkSk4d3ia5YR5nmnImc4JRRibH2iavHXMtlfX72hGg7RpA/132, createdBy=435e5183220, createdName=曼朵朵, createdTime=Tue Dec 10 10:23:16 CST 2024, time=2024-12-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2203444, encodeId=974e22034441c, content=请问3CX是要拒稿的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ceb5426566, createdName=ms7000001759450297, createdTime=Wed May 08 13:27:16 CST 2024, time=2024-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2240974, encodeId=a5bf22409e426, content=熬过了1a，又卡到了2E，这一步你们都用了多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Thu Dec 05 16:29:26 CST 2024, time=2024-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241160, encodeId=5da1224116001, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：一个月了现在2B，持续了10天……等待中，不知道这个杂志好中不？临床标志物和预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=051e2959338, createdName=cyz01, createdTime=Sat Dec 07 00:18:16 CST 2024, time=2024-12-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2241047, encodeId=0b0c224104e97, content=Conflict of Interest The Author is responsible for collecting disclosure information for each of the co-authors in a multi-authored paper. DMP's editor(s) will determine what disclosures, if any, should be made available with the published Paper. 作者负责收集多作者论文中每位合著者的披露信息。DMP 的编辑将决定应与已发布的论文一起提供哪些披露（如果有）。这句话的意思是投稿之后只有第一个作者收到确认信息，其他作者收不到投稿邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c578489111, createdName=ms2000001896994207, createdTime=Fri Dec 06 09:59:59 CST 2024, time=2024-12-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2239408, encodeId=ab39223940840, content=有兄弟遇到过3A Provisional acceptance这个状态吗？是直接接收的意思吗？心里好忐忑……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Nov 27 00:01:55 CST 2024, time=2024-11-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2239874, encodeId=b1a922398e48b, content=偏重的研究方向：心脏;炎症 经验分享：大家有过5AB：Final decision confirmation pending这个状态吗？这个是快要接收了还是不确定啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9eb25579326, createdName=一个胖子YH, createdTime=Fri Nov 29 09:30:45 CST 2024, time=2024-11-29, status=1, ipAttribution=山东省)]

2024-12-10 曼朵朵来自重庆

审稿速度:3.0
经验分享：2B已经1个月

5 0

[GetPortalCommentsPageByObjectIdResponse(id=2239946, encodeId=726f223994627, content=修改后第二轮送审了，有没有同样经历的老师，第二次送审要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Fri Nov 29 17:53:19 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2229945, encodeId=6eb72229945a9, content=请问下大家2Ereport sent to editor in chief 到给出第一次意见用了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Wed Oct 09 13:33:16 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2241724, encodeId=7ce42241e2478, content=偏重的研究方向：免疫;肿瘤;炎症 经验分享：1AB 快2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Tue Dec 10 20:16:47 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241649, encodeId=57ea2241649e8, content=审稿速度:3.0 经验分享：2B已经1个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PvPuPKyGgyEFjOnEQlhibAbJCaAxIq6qJEXfBCYLEEvWnkSk4d3ia5YR5nmnImc4JRRibH2iavHXMtlfX72hGg7RpA/132, createdBy=435e5183220, createdName=曼朵朵, createdTime=Tue Dec 10 10:23:16 CST 2024, time=2024-12-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2203444, encodeId=974e22034441c, content=请问3CX是要拒稿的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ceb5426566, createdName=ms7000001759450297, createdTime=Wed May 08 13:27:16 CST 2024, time=2024-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2240974, encodeId=a5bf22409e426, content=熬过了1a，又卡到了2E，这一步你们都用了多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Thu Dec 05 16:29:26 CST 2024, time=2024-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241160, encodeId=5da1224116001, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：一个月了现在2B，持续了10天……等待中，不知道这个杂志好中不？临床标志物和预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=051e2959338, createdName=cyz01, createdTime=Sat Dec 07 00:18:16 CST 2024, time=2024-12-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2241047, encodeId=0b0c224104e97, content=Conflict of Interest The Author is responsible for collecting disclosure information for each of the co-authors in a multi-authored paper. DMP's editor(s) will determine what disclosures, if any, should be made available with the published Paper. 作者负责收集多作者论文中每位合著者的披露信息。DMP 的编辑将决定应与已发布的论文一起提供哪些披露（如果有）。这句话的意思是投稿之后只有第一个作者收到确认信息，其他作者收不到投稿邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c578489111, createdName=ms2000001896994207, createdTime=Fri Dec 06 09:59:59 CST 2024, time=2024-12-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2239408, encodeId=ab39223940840, content=有兄弟遇到过3A Provisional acceptance这个状态吗？是直接接收的意思吗？心里好忐忑……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Nov 27 00:01:55 CST 2024, time=2024-11-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2239874, encodeId=b1a922398e48b, content=偏重的研究方向：心脏;炎症 经验分享：大家有过5AB：Final decision confirmation pending这个状态吗？这个是快要接收了还是不确定啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9eb25579326, createdName=一个胖子YH, createdTime=Fri Nov 29 09:30:45 CST 2024, time=2024-11-29, status=1, ipAttribution=山东省)]

2024-05-08 ms7000001759450297 来自广东省

请问3CX是要拒稿的意思吗

86 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2239946, encodeId=726f223994627, content=修改后第二轮送审了，有没有同样经历的老师，第二次送审要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Fri Nov 29 17:53:19 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2229945, encodeId=6eb72229945a9, content=请问下大家2Ereport sent to editor in chief 到给出第一次意见用了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Wed Oct 09 13:33:16 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2241724, encodeId=7ce42241e2478, content=偏重的研究方向：免疫;肿瘤;炎症 经验分享：1AB 快2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Tue Dec 10 20:16:47 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241649, encodeId=57ea2241649e8, content=审稿速度:3.0 经验分享：2B已经1个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PvPuPKyGgyEFjOnEQlhibAbJCaAxIq6qJEXfBCYLEEvWnkSk4d3ia5YR5nmnImc4JRRibH2iavHXMtlfX72hGg7RpA/132, createdBy=435e5183220, createdName=曼朵朵, createdTime=Tue Dec 10 10:23:16 CST 2024, time=2024-12-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2203444, encodeId=974e22034441c, content=请问3CX是要拒稿的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ceb5426566, createdName=ms7000001759450297, createdTime=Wed May 08 13:27:16 CST 2024, time=2024-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2240974, encodeId=a5bf22409e426, content=熬过了1a，又卡到了2E，这一步你们都用了多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Thu Dec 05 16:29:26 CST 2024, time=2024-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241160, encodeId=5da1224116001, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：一个月了现在2B，持续了10天……等待中，不知道这个杂志好中不？临床标志物和预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=051e2959338, createdName=cyz01, createdTime=Sat Dec 07 00:18:16 CST 2024, time=2024-12-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2241047, encodeId=0b0c224104e97, content=Conflict of Interest The Author is responsible for collecting disclosure information for each of the co-authors in a multi-authored paper. DMP's editor(s) will determine what disclosures, if any, should be made available with the published Paper. 作者负责收集多作者论文中每位合著者的披露信息。DMP 的编辑将决定应与已发布的论文一起提供哪些披露（如果有）。这句话的意思是投稿之后只有第一个作者收到确认信息，其他作者收不到投稿邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c578489111, createdName=ms2000001896994207, createdTime=Fri Dec 06 09:59:59 CST 2024, time=2024-12-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2239408, encodeId=ab39223940840, content=有兄弟遇到过3A Provisional acceptance这个状态吗？是直接接收的意思吗？心里好忐忑……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Nov 27 00:01:55 CST 2024, time=2024-11-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2239874, encodeId=b1a922398e48b, content=偏重的研究方向：心脏;炎症 经验分享：大家有过5AB：Final decision confirmation pending这个状态吗？这个是快要接收了还是不确定啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9eb25579326, createdName=一个胖子YH, createdTime=Fri Nov 29 09:30:45 CST 2024, time=2024-11-29, status=1, ipAttribution=山东省)]

2024-12-05 ms5000001180195665 来自北京

熬过了1a，又卡到了2E，这一步你们都用了多久呀

6 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2239946, encodeId=726f223994627, content=修改后第二轮送审了，有没有同样经历的老师，第二次送审要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Fri Nov 29 17:53:19 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2229945, encodeId=6eb72229945a9, content=请问下大家2Ereport sent to editor in chief 到给出第一次意见用了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Wed Oct 09 13:33:16 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2241724, encodeId=7ce42241e2478, content=偏重的研究方向：免疫;肿瘤;炎症 经验分享：1AB 快2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Tue Dec 10 20:16:47 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241649, encodeId=57ea2241649e8, content=审稿速度:3.0 经验分享：2B已经1个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PvPuPKyGgyEFjOnEQlhibAbJCaAxIq6qJEXfBCYLEEvWnkSk4d3ia5YR5nmnImc4JRRibH2iavHXMtlfX72hGg7RpA/132, createdBy=435e5183220, createdName=曼朵朵, createdTime=Tue Dec 10 10:23:16 CST 2024, time=2024-12-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2203444, encodeId=974e22034441c, content=请问3CX是要拒稿的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ceb5426566, createdName=ms7000001759450297, createdTime=Wed May 08 13:27:16 CST 2024, time=2024-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2240974, encodeId=a5bf22409e426, content=熬过了1a，又卡到了2E，这一步你们都用了多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Thu Dec 05 16:29:26 CST 2024, time=2024-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241160, encodeId=5da1224116001, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：一个月了现在2B，持续了10天……等待中，不知道这个杂志好中不？临床标志物和预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=051e2959338, createdName=cyz01, createdTime=Sat Dec 07 00:18:16 CST 2024, time=2024-12-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2241047, encodeId=0b0c224104e97, content=Conflict of Interest The Author is responsible for collecting disclosure information for each of the co-authors in a multi-authored paper. DMP's editor(s) will determine what disclosures, if any, should be made available with the published Paper. 作者负责收集多作者论文中每位合著者的披露信息。DMP 的编辑将决定应与已发布的论文一起提供哪些披露（如果有）。这句话的意思是投稿之后只有第一个作者收到确认信息，其他作者收不到投稿邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c578489111, createdName=ms2000001896994207, createdTime=Fri Dec 06 09:59:59 CST 2024, time=2024-12-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2239408, encodeId=ab39223940840, content=有兄弟遇到过3A Provisional acceptance这个状态吗？是直接接收的意思吗？心里好忐忑……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Nov 27 00:01:55 CST 2024, time=2024-11-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2239874, encodeId=b1a922398e48b, content=偏重的研究方向：心脏;炎症 经验分享：大家有过5AB：Final decision confirmation pending这个状态吗？这个是快要接收了还是不确定啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9eb25579326, createdName=一个胖子YH, createdTime=Fri Nov 29 09:30:45 CST 2024, time=2024-11-29, status=1, ipAttribution=山东省)]

2024-12-07 cyz01 来自江苏省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：炎症
经验分享：一个月了现在2B，持续了10天……等待中，不知道这个杂志好中不？临床标志物和预测模型

6 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2239946, encodeId=726f223994627, content=修改后第二轮送审了，有没有同样经历的老师，第二次送审要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Fri Nov 29 17:53:19 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2229945, encodeId=6eb72229945a9, content=请问下大家2Ereport sent to editor in chief 到给出第一次意见用了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Wed Oct 09 13:33:16 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2241724, encodeId=7ce42241e2478, content=偏重的研究方向：免疫;肿瘤;炎症 经验分享：1AB 快2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Tue Dec 10 20:16:47 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241649, encodeId=57ea2241649e8, content=审稿速度:3.0 经验分享：2B已经1个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PvPuPKyGgyEFjOnEQlhibAbJCaAxIq6qJEXfBCYLEEvWnkSk4d3ia5YR5nmnImc4JRRibH2iavHXMtlfX72hGg7RpA/132, createdBy=435e5183220, createdName=曼朵朵, createdTime=Tue Dec 10 10:23:16 CST 2024, time=2024-12-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2203444, encodeId=974e22034441c, content=请问3CX是要拒稿的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ceb5426566, createdName=ms7000001759450297, createdTime=Wed May 08 13:27:16 CST 2024, time=2024-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2240974, encodeId=a5bf22409e426, content=熬过了1a，又卡到了2E，这一步你们都用了多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Thu Dec 05 16:29:26 CST 2024, time=2024-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241160, encodeId=5da1224116001, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：一个月了现在2B，持续了10天……等待中，不知道这个杂志好中不？临床标志物和预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=051e2959338, createdName=cyz01, createdTime=Sat Dec 07 00:18:16 CST 2024, time=2024-12-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2241047, encodeId=0b0c224104e97, content=Conflict of Interest The Author is responsible for collecting disclosure information for each of the co-authors in a multi-authored paper. DMP's editor(s) will determine what disclosures, if any, should be made available with the published Paper. 作者负责收集多作者论文中每位合著者的披露信息。DMP 的编辑将决定应与已发布的论文一起提供哪些披露（如果有）。这句话的意思是投稿之后只有第一个作者收到确认信息，其他作者收不到投稿邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c578489111, createdName=ms2000001896994207, createdTime=Fri Dec 06 09:59:59 CST 2024, time=2024-12-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2239408, encodeId=ab39223940840, content=有兄弟遇到过3A Provisional acceptance这个状态吗？是直接接收的意思吗？心里好忐忑……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Nov 27 00:01:55 CST 2024, time=2024-11-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2239874, encodeId=b1a922398e48b, content=偏重的研究方向：心脏;炎症 经验分享：大家有过5AB：Final decision confirmation pending这个状态吗？这个是快要接收了还是不确定啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9eb25579326, createdName=一个胖子YH, createdTime=Fri Nov 29 09:30:45 CST 2024, time=2024-11-29, status=1, ipAttribution=山东省)]

2024-12-06 ms2000001896994207 来自天津

Conflict of Interest
The Author is responsible for collecting disclosure information for each of the co-authors in a multi-authored paper. DMP's editor(s) will determine what disclosures, if any, should be made available with the published Paper.
作者负责收集多作者论文中每位合著者的披露信息。DMP 的编辑将决定应与已发布的论文一起提供哪些披露（如果有）。这句话的意思是投稿之后只有第一个作者收到确认信息，其他作者收不到投稿邮件吗？

6 0

[GetPortalCommentsPageByObjectIdResponse(id=2239946, encodeId=726f223994627, content=修改后第二轮送审了，有没有同样经历的老师，第二次送审要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Fri Nov 29 17:53:19 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2229945, encodeId=6eb72229945a9, content=请问下大家2Ereport sent to editor in chief 到给出第一次意见用了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Wed Oct 09 13:33:16 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2241724, encodeId=7ce42241e2478, content=偏重的研究方向：免疫;肿瘤;炎症 经验分享：1AB 快2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Tue Dec 10 20:16:47 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241649, encodeId=57ea2241649e8, content=审稿速度:3.0 经验分享：2B已经1个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PvPuPKyGgyEFjOnEQlhibAbJCaAxIq6qJEXfBCYLEEvWnkSk4d3ia5YR5nmnImc4JRRibH2iavHXMtlfX72hGg7RpA/132, createdBy=435e5183220, createdName=曼朵朵, createdTime=Tue Dec 10 10:23:16 CST 2024, time=2024-12-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2203444, encodeId=974e22034441c, content=请问3CX是要拒稿的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ceb5426566, createdName=ms7000001759450297, createdTime=Wed May 08 13:27:16 CST 2024, time=2024-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2240974, encodeId=a5bf22409e426, content=熬过了1a，又卡到了2E，这一步你们都用了多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Thu Dec 05 16:29:26 CST 2024, time=2024-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241160, encodeId=5da1224116001, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：一个月了现在2B，持续了10天……等待中，不知道这个杂志好中不？临床标志物和预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=051e2959338, createdName=cyz01, createdTime=Sat Dec 07 00:18:16 CST 2024, time=2024-12-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2241047, encodeId=0b0c224104e97, content=Conflict of Interest The Author is responsible for collecting disclosure information for each of the co-authors in a multi-authored paper. DMP's editor(s) will determine what disclosures, if any, should be made available with the published Paper. 作者负责收集多作者论文中每位合著者的披露信息。DMP 的编辑将决定应与已发布的论文一起提供哪些披露（如果有）。这句话的意思是投稿之后只有第一个作者收到确认信息，其他作者收不到投稿邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c578489111, createdName=ms2000001896994207, createdTime=Fri Dec 06 09:59:59 CST 2024, time=2024-12-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2239408, encodeId=ab39223940840, content=有兄弟遇到过3A Provisional acceptance这个状态吗？是直接接收的意思吗？心里好忐忑……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Nov 27 00:01:55 CST 2024, time=2024-11-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2239874, encodeId=b1a922398e48b, content=偏重的研究方向：心脏;炎症 经验分享：大家有过5AB：Final decision confirmation pending这个状态吗？这个是快要接收了还是不确定啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9eb25579326, createdName=一个胖子YH, createdTime=Fri Nov 29 09:30:45 CST 2024, time=2024-11-29, status=1, ipAttribution=山东省)]

2024-11-27 ms8000001052932104 来自江苏省

有兄弟遇到过3A Provisional acceptance这个状态吗？是直接接收的意思吗？心里好忐忑……

12 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2239946, encodeId=726f223994627, content=修改后第二轮送审了，有没有同样经历的老师，第二次送审要多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded55595736, createdName=ms4000000082043336, createdTime=Fri Nov 29 17:53:19 CST 2024, time=2024-11-29, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2229945, encodeId=6eb72229945a9, content=请问下大家2Ereport sent to editor in chief 到给出第一次意见用了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf2b6578743, createdName=ms9000002057290162, createdTime=Wed Oct 09 13:33:16 CST 2024, time=2024-10-09, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2241724, encodeId=7ce42241e2478, content=偏重的研究方向：免疫;肿瘤;炎症 经验分享：1AB 快2周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65ab5425857, createdName=Doctorfan, createdTime=Tue Dec 10 20:16:47 CST 2024, time=2024-12-10, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2241649, encodeId=57ea2241649e8, content=审稿速度:3.0 经验分享：2B已经1个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PvPuPKyGgyEFjOnEQlhibAbJCaAxIq6qJEXfBCYLEEvWnkSk4d3ia5YR5nmnImc4JRRibH2iavHXMtlfX72hGg7RpA/132, createdBy=435e5183220, createdName=曼朵朵, createdTime=Tue Dec 10 10:23:16 CST 2024, time=2024-12-10, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2203444, encodeId=974e22034441c, content=请问3CX是要拒稿的意思吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5ceb5426566, createdName=ms7000001759450297, createdTime=Wed May 08 13:27:16 CST 2024, time=2024-05-08, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2240974, encodeId=a5bf22409e426, content=熬过了1a，又卡到了2E，这一步你们都用了多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20ca9391113, createdName=ms5000001180195665, createdTime=Thu Dec 05 16:29:26 CST 2024, time=2024-12-05, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2241160, encodeId=5da1224116001, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：炎症 经验分享：一个月了现在2B，持续了10天……等待中，不知道这个杂志好中不？临床标志物和预测模型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/img/user_icon.png, createdBy=051e2959338, createdName=cyz01, createdTime=Sat Dec 07 00:18:16 CST 2024, time=2024-12-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2241047, encodeId=0b0c224104e97, content=Conflict of Interest The Author is responsible for collecting disclosure information for each of the co-authors in a multi-authored paper. DMP's editor(s) will determine what disclosures, if any, should be made available with the published Paper. 作者负责收集多作者论文中每位合著者的披露信息。DMP 的编辑将决定应与已发布的论文一起提供哪些披露（如果有）。这句话的意思是投稿之后只有第一个作者收到确认信息，其他作者收不到投稿邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c578489111, createdName=ms2000001896994207, createdTime=Fri Dec 06 09:59:59 CST 2024, time=2024-12-06, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2239408, encodeId=ab39223940840, content=有兄弟遇到过3A Provisional acceptance这个状态吗？是直接接收的意思吗？心里好忐忑……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f81d9214325, createdName=ms8000001052932104, createdTime=Wed Nov 27 00:01:55 CST 2024, time=2024-11-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2239874, encodeId=b1a922398e48b, content=偏重的研究方向：心脏;炎症 经验分享：大家有过5AB：Final decision confirmation pending这个状态吗？这个是快要接收了还是不确定啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9eb25579326, createdName=一个胖子YH, createdTime=Fri Nov 29 09:30:45 CST 2024, time=2024-11-29, status=1, ipAttribution=山东省)]

2024-11-29 一个胖子YH 来自山东省

偏重的研究方向：心脏;炎症
经验分享：大家有过5AB：Final decision confirmation pending这个状态吗？这个是快要接收了还是不确定啊

7 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务